Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond

Author： Malhotra Samir Bhasin Deepak Shafiq Nusrat Pandhi Promila

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins (LMWHs) could replace unfractionated heparin for the first-line treatment of ACS

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin

By Jones Terry E Smith Brian J Polasek Jonathen F

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1887-1897

Informa Healthcare

Access to resources Recommend Favorite

The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke

By Kiphuth Ines C Köhrmann Martin Huttner Hagen B Schellinger Peter D

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 585-597

Informa Healthcare

Access to resources Recommend Favorite

Heparin/low-molecular-weight heparins: Thrombocytopenia in an infant: case report

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Low molecular weight heparins

By Aguilar O.M. Kleiman N.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite